Literature DB >> 3153055

Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure.

D R Powell1, R G Rosenfeld, R L Hintz.   

Abstract

We examined the effects of methionyl-human growth hormone (met-hGH) and malnutrition on the growth of 5/6 nephrectomized rats and sham-operated controls. One group of sham-operated rats (PFS) was pair-fed with a group of nephrectomized rats in renal failure (RF); another group of sham-operated rats was fed ad libitum (ALS), and a final group of rats with renal failure (RF-GH) was treated with 4 IU/day met-hGH. After 4 weeks, RF-GH rats gained 12.3 +/- 1.7 cm in length; this was more than the 10.2 +/- 1.2 cm gain of RF rats (P less than 0.05). Ingested food was converted into weight gain more efficiently by RF-GH rats than RF rats (267 +/- 26 vs 235 +/- 38 mg weight gain/g food intake, P less than 0.05). RF-GH rats also gained more weight (122 +/- 25 g) than RF rats (98 +/- 27 g), but this difference was not significant (0.05 less than P less than 0.1). Insulin-like growth factor (IGF)-I, glucose and insulin levels were not different between RF and RF-GH rats. Food intake of RF and PFS rats was 64% of ALS intake and was associated with poor gains in weight and length by the PFS and RF groups (relative weight and length gains were ALS greater than PFS greater than RF, P less than 0.05 for all comparisons); this suggests that the poor growth of RF rats when compared with PFS rats was due to factors other than food intake. Serum IGF-I levels of 771 +/- 249 ng/ml in PFS rats were lower than levels of 1109 +/- 253 ng/ml found in the ALS group (P less than 0.05); this is consistent with the malnourished state of PFS rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3153055     DOI: 10.1007/bf00853436

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  37 in total

1.  Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.

Authors:  A T Soliman; A E Hassan; M K Aref; R L Hintz; R G Rosenfeld; A D Rogol
Journal:  Pediatr Res       Date:  1986-11       Impact factor: 3.756

2.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Growth pattern and dietary intake of children with chronic renal insufficiency.

Authors:  P R Betts; G Magrath
Journal:  Br Med J       Date:  1974-04-27

4.  Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation.

Authors:  J M Simmons; C J Wilson; D E Potter; M A Holliday
Journal:  N Engl J Med       Date:  1971-09-16       Impact factor: 91.245

5.  Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.

Authors:  R G Rosenfeld; D M Wilson; L A Dollar; A Bennett; R L Hintz
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

6.  Glucose intolerance in uremia: site and mechanism.

Authors:  R A DeFronzo; A Alvestrand
Journal:  Am J Clin Nutr       Date:  1980-07       Impact factor: 7.045

7.  Antiserum developed for the E peptide region of insulin-like growth factor IA prohormone recognizes a serum protein by both immunoblot and radioimmunoassay.

Authors:  D R Powell; P D Lee; D Chang; F Liu; R L Hintz
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

8.  Somatomedin inhibitor in uremia.

Authors:  L S Phillips; A C Fusco; T G Unterman; F del Greco
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

9.  Parathyroid function and vitamin D metabolism during human growth hormone replacement.

Authors:  J M Gertner; R L Horst; A E Broadus; H Rasmussen; M Genel
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

Review 10.  Statural growth of children with renal disease.

Authors:  D E Potter; I Greifer
Journal:  Kidney Int       Date:  1978-10       Impact factor: 10.612

View more
  11 in total

1.  Effect of growth hormone on kidney growth and glomerular structure.

Authors:  W C Arnold; B Shirkey; P Frindik; E Ellis
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

2.  Treatment of short stature in renal disease with recombinant human growth hormone.

Authors:  L Rees; S P Rigden; G Ward; M A Preece
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

3.  The effect of growth hormone on the growth failure of chronic renal failure.

Authors:  F Santos; J C Chan; J D Hanna; K Niimi; R J Krieg; M D Wellons
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

4.  Effects of growth hormone administration in pediatric renal allograft recipients.

Authors:  S Bartosh; B Kaiser; I Rezvani; M Polinsky; S Schulman; J Palmer; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

5.  Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure.

Authors:  E M Hodson; A S Brown; L P Roy; A R Rosenberg
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

Review 6.  Growth hormone therapy in children with CKD after more than two decades of practice.

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2015-09-14       Impact factor: 3.714

7.  Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome.

Authors:  R N Fine; K Pyke-Grimm; P A Nelson; M I Boechat; B M Lippe; O Yadin; E Kamil
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

8.  Somatic growth in corticosteroid-treated rats with passive Heymann nephritis--effects of recombinant human growth hormone on growth impairment.

Authors:  H Kawaguchi; M Hattori; M Kohno; K Ito; N Hizuka; K Takano
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

9.  Acidosis prevents growth hormone-induced growth in experimental uremia.

Authors:  C Kleinknecht; S Maniar; X Zhou; V Motel; D Laouari; J P Yvert; M Dechaux
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

10.  Growth hormone and insulin-like growth factor-I and mesangial matrix in uremic rats.

Authors:  J J Lin; R N Fine; F J Kaskel
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.